⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 4 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 4 hours ago
🛡️ EUSW
🇬🇧
💊 Medicine AT April 7, 2026

Dabigatranetexilat 1A Pharma 150 mg - Hartkapseln 150 mg (Hartkapsel)

📷 Wikipedia: Dabigatran · Source
Dabigatranetexilat 1A Pharma 150 mg - Hartkapseln 150 mg (Hartkapsel)
📷 Wikipedia: Dabigatran · Source
Dabigatranetexilate 1A Pharma 150 mg hard capsules.
⚠️
Shortage ongoing
DABIGATRANETEXILATMESILAT is currently in short supply in AT.
📈 Timeline
10 days active so far
May 18, 2026 May 27, 2026

What is this? Dabigatranetexilat is a medicine in capsules. It helps stop blood clots.

What's happening? The 150 mg capsules in 30-count boxes are out of stock. The 60-count boxes are still available.

Does this affect me? If you take this medicine, check your box size. The smaller pack is missing.

What should I do? Ask your pharmacist or doctor for advice before changing how you take your medicine.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
Agency-published detail

ATC: B01AE07 · Reason: Erhöhter Mehrbedarf · Marketing authorisation holder: 1 A Pharma GmbH, Jakov-Lind-Straße 5/3.05, 1020 Wien, Österreich · Affected packs: 30 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-04-07] · 60 Stück Schachtel, Blisterpackung [verfügbar]

First published
April 7, 2026
Last refreshed by us
16 hours ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

❓ Frequently asked questions

What is this medicine shortage alert about?
Dabigatranetexilat 1A Pharma 150 mg - Hartkapseln 150 mg (Hartkapsel). Dabigatranetexilate 1A Pharma 150 mg hard capsules.
When was this alert issued?
This alert was issued on April 7, 2026 by BASG (Austria).
Which countries are affected?
The alert applies to Austria.
How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.